Müller + Müller is based in Holzminden in Lower Saxony, Germany, and currently employs 135 staff. The family-run company is a key player in the manufacture of vials and has a long history of over 95 years. Thanks to its state-of-the-art technology and continuous process optimisation, Müller + Müller meets the highest quality requirements for pharmaceutical packaging. Every year approx. 300 million glass type I vials are produced at its Holzminden site in accordance with GMP guidelines. Type I borosilicate glass is an excellent material for storing vaccines as the glass is virtually inert. This means that the container glass does not react with its contents and thus represents the standard in vaccine packaging.

“Acquiring the family business Müller + Müller is a significant strategic step for us in expanding our activities in the market for pharmaceuticals packaging,” explains CEO of DWK Life Sciences, Armin Reiche.  “We are not just investing in an important growth market here, but also in a company that boasts first class production technology and highly reliable products.” 

“Driven by the high demand of the vaccine industry for vials, expansion of our production capacities is the next logical step,” says Florian Müller-Stauch, CEO of Müller + Müller. “We are delighted to have found a strong and reliable partner in DWK who will allow us to further develop our business.”

DWK Life Sciences is a portfolio company of One Equity Partners, a middle market private equity firm that builds market-leading companies by identifying and executing transformative business combinations and partnering with management teams to provide operational support to accelerate growth.

About Müller + Müller

Müller + Müller is one of the world’s leading manufacturers of primary packaging materials made of tubular glass for the pharmaceuticals industry. Its clear focus and over 90 years of experience in the field of tubular glass vials show that the company is well positioned to be a reliable and growth-minded partner to its customers in the future.

Its manufacturing base in Holzminden (southern Lower Saxony) produces approx. 300 million vials every year on state-of-the-art production lines. Production meets the highest quality standards and complies with DIN EN ISO 9001:2008 and DIN ISO 15378:2011 (GMP standard).